Two Drugs Offer Hope Against Prostate Cancer
Two cancer drugs can stall the progression of a particularly hard-to-treat form of prostate cancer, a pair of new trials shows.
Enzalutamide may have a role in prostate cancer therapy, but randomized trials are needed, says Dr Chodak.Medscape Urology
Condition: Prostate Cancer Recurrent Intervention: Drug: Ga-68 P16-093 PET/CT scan Sponsors: Five Eleven Pharma, Inc.; Indiana University Recruiting
Conditions: Cancer of Prostate; Insomnia Intervention: Behavioral: 12-week aerobic exercise and cognitive-behavioral therapy Sponsor: Danish Cancer Society Not yet recruiting
Condition: Prostate Cancer Recurrent Intervention: Diagnostic Test: 68Ga-HBED-CC-PSMA PET / CT Sponsor: Institut Cancerologie de l'Ouest Recruiting
The presenter had surgery for prostate cancer and says "it all seemed to go pretty well".
PROSTATE cancer symptoms don ’t usually show until the latter stages of the disease. After Stephen Fry was diagnosed with the condition, what are the signs to look out for?
STEPHEN FRY revealed today he has been battling prostate cancer, but what are symptoms of the condition, how can you test for it, and what treatment can you expect?
ConclusionsEarlier induction of docetaxel in nmCRPC patients may prolong OS. Further prospective studies in more patients will be required to confirm our findings.
CONCLUSIONS: The combination of TBx and SBx achieved the best results for the detection and prognosis of PCa-s. The use of SBx alone would have missed the detection of PCa-s in 12% of patients. PMID: 29463177 [PubMed - as supplied by publisher]
CONCLUSIONS: Low-dose brachytherapy offers good short- to intermediate-term cancer control in selected men with localized PCa. Further studies are needed for safety analyses and for comparison with other treatment modalities. PMID: 29463165 [PubMed - as supplied by publisher]